ARCHIVES

HRSA: Discounts Owed on Some Orphan Drug Uses

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Review Process A Disaster, Borek Says

October 19, 1979

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008

In Brief: NIH Scientist, NIH Grantee Win Nobel Prize; DOD Breast Cancer Research Funded For ‘95

October 14, 1994

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009